This is a competing renewal application for continuation of the Univ of Chicago Research Training Program in Respiratory Biology. The objective of this Program is to prepare young scientists to pursue research careers addressing mechanisms and treatment of human disease, with focus on respiratory pathobiology. The training faculty are 26 well established scientists of diverse backgrounds from 9 departments at Univ of Chicago, Univ of Illinois, and Northwestern Univ: The cohesiveness of this interdisciplinary Program stems from the highly collaborative nature of these faculty, who are drawn together by common programmatic interest in 2 areas of research concentration: Airway Biology, and Oxygen Deprivation/Critical Care. Studies in Airway Biology focus on airway inflammation, airway smooth muscle and epithelial structure and function, B-cell and T-cell activation, and asthma genetics. Studies of Oxygen Deprivation/ Critical Care address subcellular determinants of oxygen sensing and consumption, cellular responses to hypoxia, cell homeostasis, membrane biology, ischemic injury, and extensions in critically ill patients and in patients with cardiopulmonary arrest. A broad range of approaches taken in each research concentration includes transgenic and gene transfer models in vivo, experimental manipulation of isolated or cultured cells, genetic mapping, genomics and proteomics, and clinical physiology. Ample research funding from NIH and other agencies is in place to support these studies. The Program Director is Julian Solway, MD, Professor of Medicine and Pediatrics. Assistance with day-to-day oversight is provided by 2 senior faculty members (Drs. Alan Leff and Paul Schumacker), and by Dr. Anne Sperling, Asst Director for Mentorship (Dr. Anne Sperling). An Executive Committee comprised of senior scientists (outside the Training Faculty) will meet yearly to provide external oversight, and an Admissions Committee comprised of senior Training Faculty members will meet quarterly to provide regular Program and trainee review. Funding is requested for 10 post-doctoral and 4 pre-doctoral trainees. PhD and MD post-doctoral trainees will be enrolled in approximately equal numbers and will be trained together. All fellows perform full-time research for at least 2 years, and MD fellows will not receive clinical training while supported by this Training Grant. Pre-doctoral candidates are drawn from the graduate and MSTP programs of the Univ of Chicago. The Training Program includes 4 components: The Research Project is an in-depth, hands-on research training experience performed under the direct supervision of training faculty mentors. The Core Curriculum of formal teaching sessions includes Research in Progress Seminars, an Advanced Respiratory Pathophysiology course, a Seminar Series run by the Committee on Molecular Medicine, and a Responsible Conduct of Research program;additional formal course work is tailored for each trainee. Learning of Survival Skills (Scientific Communication, Grant Writing, and Mentoring) comprises the third component, and exposure to Multidisciplinary Research is the fourth. Prior trainees from this program have developed successful independent research careers in large proportion. Refinements presented here should further enhance the likelihood for success of future trainees.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007605-25
Application #
7650086
Study Section
Special Emphasis Panel (ZHL1-CSR-G (F1))
Program Officer
Colombini-Hatch, Sandra
Project Start
1985-06-01
Project End
2010-06-30
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
25
Fiscal Year
2009
Total Cost
$549,597
Indirect Cost
Name
University of Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Maisel, Katharina; Merrilees, Mervyn J; Atochina-Vasserman, Elena N et al. (2018) Immune Checkpoint Ligand PD-L1 Is Upregulated in Pulmonary Lymphangioleiomyomatosis. Am J Respir Cell Mol Biol 59:723-732
Patel, Bhakti K; Wendlandt, Blair N; Wolfe, Krysta S et al. (2018) Comparison of Two Lidocaine Administration Techniques on Perceived Pain From Bedside Procedures: A Randomized Clinical Trial. Chest 154:773-780
Parker, William F; Anderson, Allen S; Hedeker, Donald et al. (2018) Geographic Variation in the Treatment of U.S. Adult Heart Transplant Candidates. J Am Coll Cardiol 71:1715-1725
Adegunsoye, Ayodeji; Oldham, Justin M; Chung, Jonathan H et al. (2018) Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort. Chest 153:349-360
Adegunsoye, Ayodeji; Oldham, Justin M; Bellam, Shashi K et al. (2018) African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis. Eur Respir J 51:
Parker, William Fiske; Ross, Lainie Friedman; Richard Thistlethwaite Jr, J et al. (2018) Impact of the kidney allocation system on young pediatric recipients. Clin Transplant 32:e13223
Hrusch, C L; Manns, S T; Bryazka, D et al. (2018) ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s. Mucosal Immunol 11:61-70
Wu, David; Woods, Parker S; Duong, Heng T et al. (2018) Role of Cellular Metabolism in Pulmonary Diseases. Am J Respir Cell Mol Biol 59:127-129
Patel, Bhakti K; Wolfe, Krysta S; MacKenzie, Erica L et al. (2018) One-Year Outcomes in Patients With Acute Respiratory Distress Syndrome Enrolled in a Randomized Clinical Trial of Helmet Versus Facemask Noninvasive Ventilation. Crit Care Med 46:1078-1084
Duong, Heng; Bonham, Catherine A (2018) Sarcoidosis-associated Pulmonary Hypertension: Pathophysiology, Diagnosis, and Treatment. Clin Pulm Med 25:52-60

Showing the most recent 10 out of 144 publications